Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
ATP-binding cassette transporter B1 (ABCB1; P-glycoprotein; multidrug resistance protein 1)
is an adenosine triphosphate (ATP)-dependent efflux transporter located in the plasma …
is an adenosine triphosphate (ATP)-dependent efflux transporter located in the plasma …
Genetic polymorphisms and paclitaxel-or docetaxel-induced toxicities: a systematic review
CN Frederiks, SW Lam, HJ Guchelaar, E Boven - Cancer treatment reviews, 2015 - Elsevier
Background Taxanes, including paclitaxel and docetaxel, are indispensable for treatment of
cancer. Development of toxicity frequently necessitates dose reduction or discontinuation of …
cancer. Development of toxicity frequently necessitates dose reduction or discontinuation of …
Cytochrome P450 in cancer susceptibility and treatment
B Mittal, S Tulsyan, S Kumar, RD Mittal… - Advances in clinical …, 2015 - Elsevier
Abstract Cytochrome 450 (CYP450) designates a group of enzymes abundant in smooth
endoplasmic reticulum of hepatocytes and epithelial cells of small intestines. The main …
endoplasmic reticulum of hepatocytes and epithelial cells of small intestines. The main …
Toxicity and pharmacogenomic biomarkers in breast cancer chemotherapy
Breast cancer (BC) is one of the most prevalent types of cancer worldwide with high
morbidity and mortality rates. Treatment modalities include systemic therapy, in which …
morbidity and mortality rates. Treatment modalities include systemic therapy, in which …
[HTML][HTML] Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
K Tecza, J Pamula-Pilat, J Lanuszewska… - Oncotarget, 2018 - ncbi.nlm.nih.gov
The differences in patients' response to the same medication, toxicity included, are one of
the major problems in breast cancer treatment. Chemotherapy toxicity makes a significant …
the major problems in breast cancer treatment. Chemotherapy toxicity makes a significant …
Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells
F El Khoury, L Corcos, S Durand… - International …, 2016 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most aggressive cancers worldwide. Several
anticancer agents are available to treat CRC, but eventually cancer relapse occurs. One …
anticancer agents are available to treat CRC, but eventually cancer relapse occurs. One …
The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment
S Tulsyan, RD Mittal, B Mittal - … and personalized medicine, 2016 - Taylor & Francis
The ABCB1 gene encodes a permeability glycoprotein, which is one of the most extensively
studied human adenosine-triphosphate (ATP)-dependent efflux transporters. Permeability …
studied human adenosine-triphosphate (ATP)-dependent efflux transporters. Permeability …
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel
AJM de Graan, CS Lancaster, A Obaidat… - Clinical Cancer …, 2012 - AACR
Purpose: Docetaxel is extensively metabolized by CYP3A4 in the liver but mechanisms by
which the drug is taken up into hepatocytes remain poorly understood. We hypothesized that …
which the drug is taken up into hepatocytes remain poorly understood. We hypothesized that …
[HTML][HTML] SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
R Palmirotta, C Carella, E Silvestris, M Cives… - Oncotarget, 2018 - ncbi.nlm.nih.gov
In the “precision medicine” era, chemotherapy still remains the backbone for the treatment of
many cancers, but no affordable predictors of response to the chemodrugs are available in …
many cancers, but no affordable predictors of response to the chemodrugs are available in …
Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity
Interindividual variability in drug response and the emergence of adverse drug effects are
the main causes of treatment failure in cancer therapy. Functional membrane drug …
the main causes of treatment failure in cancer therapy. Functional membrane drug …